Quick Links

Credit Designation

This program is accredited for physicians.

Physician Accreditation Statement – This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Physician’s Education Resource, LLC. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation - Purdue University College of Pharmacy designates this Live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty, Staff and Reviewer Disclosure Statement - All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships will be made in writing to the audience prior to the activity. All additional planning committee members, staff and reviewers of Physician’s Education Resource, LLC. and Purdue University College of Pharmacy have no relationships to disclose.
Privacy Policy
Terms & Conditions
Executive Board
Faculty Portal
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

American Diabetes Association’s 78th Scientific Sessions

American Diabetes Association’s 78th Scientific Sessions

Date: Monday, June 25, 2018
Session: 6:45 PM – 9:45 PM ET
Location: Hyatt Regency Orlando
9801 International Drive
Orlando, Florida
Room: Regency Ballroom

Program Overview

Through a Medical Crossfire®, faculty will provide expert interpretation and guidance on the impact/clinical application of recent cardiovascular outcomes trials (CVOTs) for achieving glycemic control with SGLT2 inhibitors. Participant interactivity and Infograph-ed™ will be included to better understand and incorporate cardio metabolic risk reduction strategies into practice.

Learning Objectives

  • Articulate reasons that persons with type 2 diabetes (T2D) fail to achieve target A1C goals and reduce cardiometabolic risk factors
  • List the potential clinical benefits for achieving glycemic control with newer therapies, especially SGLT2 inhibitors, in persons with T2D and cardiometabolic risk factors at various stages of the disease
  • Discuss results of recent large-scale cardiovascular outcomes trials in persons with T2D
  • Develop individualized approaches for effectively improving outcomes in persons with T2D and cardiometabolic risk factors

Become a Member

Forgot Password?
Calendar of Events
Filter By